Drugs / TAK-536CCB
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02072330 Comparator | Mar → Dec 2013 | essential hypertension | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-536CCB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02072330 ↗ |
| Known as | Fix-dose combination of Azilsartan and Amlodipine | “Fix-dose combination of Azilsartan and Amlodipine” NCT02072330 ↗ |